IP Library Granted Patent US 8,333,199
Granted Patent B2
US 8,333,199 · App. 12/347,409 · Granted Dec 18, 2012

High flow therapy artificial airway interfaces and related methods

Assignee: Mergenet Medical, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,333,199
App. No.
12/347,409
Granted
Dec 18, 2012
Kind
B2
Abstract

Embodiments of the present invention provide a device, system and method for providing high flow therapy interfaces for use in the treatment of respiratory conditions and in assisted respirations. In an embodiment of the invention, a nasal cannula for delivery of respiratory gases can include at least one nasal insert and at least one flange coupled to the at least one nasal insert where the at least one flange is configured to partially impede the egress of respiratory gasses delivered to an upper airway of a patient is provided. In another embodiment, a flange has a shape selected from the group consisting of a slotted, vented or slitted design and configured to partially impede the egress of respiratory gasses.

Claims (11)

1. A nasal cannula for delivery of respiratory gases, the nasal cannula comprising:

at least one nasal insert; and

at least one flange coupled to the at least one nasal insert, the at least one flange configured to partially impede the egress of respiratory gasses delivered to an upper airway of a patient, wherein the at least one flange includes a top surface defining a corresponding top surface area,

wherein the at least one flange further includes at least one slot defining a corresponding implicit surface area, the top surface area of the top surface being substantially greater than the implicit surface area of the at least one slot; and

a flange retention connector configured to receive a detachable flange.

2. The nasal cannula of claim 1 , wherein the flange is configured to fit within the nostril of a patient.

3. The nasal cannula of claim 1 , wherein the flange is configured to fit outside the nostril of a patient.

4. The nasal cannula of claim 1 , wherein the nasal insert has two lumens.

5. A flange for a nasal cannula, the flange configured to detachably couple to a flange retention connector, the flange configured to partially impede the egress of respiratory gasses, wherein the at least one flange includes a top surface defining a corresponding top surface area, and wherein the at least one flange further includes at least one slot defining a corresponding implicit surface area, the top surface area of the top surface being substantially greater than the implicit surface area of the at least one slot.

6. The flange of the nasal cannula of claim 5 , wherein the flange is configured to fit within the nostril of a patient.

7. The flange of the nasal cannula of claim 5 , wherein the flange is configured to fit outside the nostril of a patient.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 2, 2021
From: MERGENET MEDICAL, INC.
To: RESMED PTY LTD
Reel/Frame 056418/0880 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 6, 2009
From: LANDIS, ROBERT M.; LEWIS, CHARLES A.
To: MERGENET MEDICAL, INC.
Reel/Frame 022060/0710 →
Continuity (8)
Continuation In Part 11638981 · Dec 14, 2006
Continuation In Part 11520490 · Sep 12, 2006
Provisional Application 61009702 · Dec 31, 2007
Provisional Application 60716776 · Sep 12, 2005
Provisional Application 60750063 · Dec 14, 2005
Provisional Application 60792711 · Apr 18, 2006
Provisional Application 60852851 · Oct 18, 2006
Related Publication 20090101147A1 · Apr 23, 2009